ENPP7
Basic information
Region (hg38): 17:79730943-79742219
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ENPP7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 6 | 0 |
Variants in ENPP7
This is a list of pathogenic ClinVar variants found in the ENPP7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-79731180-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
17-79731207-C-T | Malignant tumor of prostate | Uncertain significance (-) | ||
17-79731275-G-C | not specified | Uncertain significance (Jan 11, 2023) | ||
17-79731284-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
17-79731333-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
17-79733566-G-T | not specified | Uncertain significance (Apr 01, 2024) | ||
17-79733618-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
17-79733624-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
17-79735107-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
17-79735164-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
17-79735277-A-G | not specified | Uncertain significance (Apr 12, 2024) | ||
17-79735292-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
17-79735298-G-A | not specified | Uncertain significance (Mar 21, 2024) | ||
17-79735304-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
17-79735320-T-A | not specified | Uncertain significance (Jul 14, 2021) | ||
17-79735334-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
17-79735352-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
17-79735361-A-G | not specified | Uncertain significance (Feb 13, 2024) | ||
17-79735385-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
17-79735392-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
17-79735407-G-A | not specified | Likely benign (Jun 13, 2023) | ||
17-79735415-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
17-79735454-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
17-79735488-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
17-79735574-A-C | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ENPP7 | protein_coding | protein_coding | ENST00000328313 | 5 | 11341 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.18e-14 | 0.00314 | 121845 | 237 | 3666 | 125748 | 0.0156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.478 | 326 | 303 | 1.08 | 0.0000212 | 2989 |
Missense in Polyphen | 130 | 119.33 | 1.0894 | 1320 | ||
Synonymous | 0.333 | 136 | 141 | 0.964 | 0.0000117 | 941 |
Loss of Function | -0.961 | 19 | 15.0 | 1.27 | 7.32e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.121 | 0.120 |
Ashkenazi Jewish | 0.00319 | 0.00308 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.000464 | 0.000462 |
European (Non-Finnish) | 0.000439 | 0.000431 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.000231 | 0.000229 |
Other | 0.0115 | 0.0111 |
dbNSFP
Source:
- Function
- FUNCTION: Converts sphingomyelin to ceramide and phosphocholine (PubMed:12885774, PubMed:12671034, PubMed:15205117, PubMed:28292932). Has also phospholipase C activity and can cleave phosphocholine from palmitoyl lyso-phosphatidylcholine (PubMed:12885774). Does not have nucleotide pyrophosphatase activity (PubMed:12885774). {ECO:0000269|PubMed:12671034, ECO:0000269|PubMed:12885774, ECO:0000269|PubMed:15205117, ECO:0000269|PubMed:28292932}.;
- Pathway
- Sphingolipid metabolism - Homo sapiens (human);Sphingolipid Metabolism;Gaucher Disease;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy (MLD);Fabry disease;Krabbe disease;Metabolism of lipids;sphingomyelin metabolism/ceramide salvage;Metabolism;Glycosphingolipid metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.715
- rvis_EVS
- 0.52
- rvis_percentile_EVS
- 80.36
Haploinsufficiency Scores
- pHI
- 0.0944
- hipred
- N
- hipred_score
- 0.275
- ghis
- 0.416
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.979
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Enpp7
- Phenotype
- digestive/alimentary phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- sphingomyelin metabolic process;sphingomyelin catabolic process;glycosphingolipid metabolic process;negative regulation of DNA replication;negative regulation of cell population proliferation
- Cellular component
- Golgi apparatus;plasma membrane;integral component of plasma membrane;microvillus;membrane
- Molecular function
- sphingomyelin phosphodiesterase activity;zinc ion binding